2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Top Cited Papers
Open Access
- 2 April 2012
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 64 (5) , 625-639
- https://doi.org/10.1002/acr.21641
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rateAnnals of the Rheumatic Diseases, 2009
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative studyClinical Rheumatology, 2006
- Autoantibodies in rheumatoid arthritis: association with severity of disease in established RAClinical Rheumatology, 2006
- Developing Quality Indicators for Elderly Patients Undergoing Abdominal OperationsJournal of the American College of Surgeons, 2005
- American college of rheumatology preliminary definition of improvement in rheumatoid arthritisArthritis & Rheumatism, 1995
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988